الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 241 |  |  |
| | | from | 241 | | |
Abstract
Spasticity is one component of the UMN syndrome. It has deleterious motor consequences which affect activity of daily living. Early intervention and optimal therapy prevents long term complications. Initially, the individual patient should be thoroughly assessed, the goal of treatment determined by agreement between the practitioner and the patient, and a comprehensive treatment plan initiated. Short-term aim of treatment is to improve ease of motion while long-term aim is to prevent soft tissue and bony deformity. The plan of treatment should include the avoidance of spasticity- aggravating factors, frequent range of motion exercise and use of mobility aids and wheelchair seating. The use of any treatment modality should be tailored according to the patient condition. Generalized spasticity needs oral/ intrathecal medications. Patients receiving antispasticity meditation should be reviewed periodically to assess response to treatment, as well as side effects. Botulinum toxin can be added in as a focal treatment for spasticity. Selective dorsal rhizotomy is used for severe spasticity in the lower limbs.